Angiodynamics (ANGO) Total Liabilities (2011 - 2026)
Angiodynamics' (ANGO) quarterly Total Liabilities came in at $96.3 million in Q2 2026, down 0.86% YoY from $97.2 million in Q2 2025, and up 10.33% on a QoQ basis from $87.3 million in Q1 2026.
Angiodynamics (ANGO) Total Liabilities (2011 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 16 years of Total Liabilities data on file, last reported at $96.3 million in Q2 2026.
- Quarterly Total Liabilities fell 0.86% year-over-year to $96.3 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $96.3 million (down 0.86% YoY) and the FY2026 annual result came in at $96.3 million, down 0.86% from the prior year.
- Total Liabilities grew to $96.3 million in Q2 2026, from $87.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $154.3 million in Q2 2023 to a low of $66.1 million in Q3 2023.
- A 5-year average of $110.0 million and a median of $102.2 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities tumbled 53.94% — and 2024, when it surged 46.72%.
- Tracing ANGO's Total Liabilities over 5 years: stood at $150.2 million in 2022, then plunged by 34.51% to $98.4 million in 2023, then climbed by 6.49% to $104.8 million in 2024, then retreated by 10.91% to $93.3 million in 2025, then gained by 3.2% to $96.3 million in 2026.
- The last three Total Liabilities figures came in at $96.3 million (Q2 2026), $87.3 million (Q1 2026), and $93.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 2.58 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 50.73 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 9.50 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 2.38 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 20.27 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 1.09 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 9.44 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 4.24 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 13.61 Bn |
| 10 | Angiodynamics | 658.19 Mn | 604.32 Mn | 46.77 Mn | 96.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 96.34 Mn |
| Feb 28, 2026 | 87.32 Mn |
| Nov 30, 2025 | 93.35 Mn |
| Aug 31, 2025 | 86.79 Mn |
| May 31, 2025 | 97.17 Mn |
| Feb 28, 2025 | 99.55 Mn |
| Nov 30, 2024 | 104.78 Mn |
| Aug 31, 2024 | 97.05 Mn |
| May 31, 2024 | 112.09 Mn |
| Feb 29, 2024 | 106.14 Mn |
| Nov 30, 2023 | 98.40 Mn |
| Aug 31, 2023 | 66.15 Mn |
| May 31, 2023 | 154.34 Mn |
| Feb 28, 2023 | 145.19 Mn |
| Nov 30, 2022 | 150.25 Mn |
| Aug 31, 2022 | 143.61 Mn |
| May 31, 2022 | 128.26 Mn |
| Feb 28, 2022 | 113.49 Mn |
| Nov 30, 2021 | 121.74 Mn |
| Aug 31, 2021 | 119.81 Mn |